Business Trip
Een podcast door Greg Kubin & Matias Serebrinsky - Donderdagen
59 Afleveringen
-
What's wrong with US healthcare and how startups can fix it, with Justin Mares
Gepubliceerd: 17-4-2025 -
Frontier investable areas in brain health with PsyMed Ventures
Gepubliceerd: 25-2-2025 -
Temporal Interference: The Future of Brain Stimulation with Nir Grossman
Gepubliceerd: 30-1-2025 -
The State of Autism Part 2 with James Adams of Gut-Brain-Axis Therapeutics Inc.
Gepubliceerd: 26-12-2024 -
The State of Autism Part 1 with Elizabeth Horn of 2m Foundation
Gepubliceerd: 12-12-2024 -
Genetic Medicine for Brain Health with Dana Watt of Breakout Ventures
Gepubliceerd: 14-11-2024 -
Transcranial Focused Ultrasound for Mental Health with Jay Sanguinetti of Sanmai
Gepubliceerd: 5-9-2024 -
Navigating FDA clinical trials in Neurotech with Tim Marjenin
Gepubliceerd: 23-8-2024 -
Environmental Toxins and Mental Health with Gurdane Bhutani
Gepubliceerd: 18-7-2024 -
FDA advisors say no to MDMA. What’s the impact? With Josh Hardman
Gepubliceerd: 21-6-2024 -
Investing in New Frontiers of Mental Health (Live at SXSW)
Gepubliceerd: 7-5-2024 -
Comparing Psychedelic Compounds in Therapy (Live Panel at Battery SF)
Gepubliceerd: 9-4-2024 -
What Payers Want with Lili Brillstein
Gepubliceerd: 14-3-2024 -
Decoding the Brain with Ed Boyden
Gepubliceerd: 22-2-2024 -
5-MeO-DMT in mental healthcare with Steve Rio
Gepubliceerd: 25-1-2024 -
Tom Insel: Startups, AI, Psychedelics, and SSRIs
Gepubliceerd: 15-12-2023 -
Food as Medicine for Mental Health: Drew Ramsey
Gepubliceerd: 30-11-2023 -
Ketogenic Diet for Brain Health: Jan Baszucki
Gepubliceerd: 16-11-2023 -
Investing in Neurotech 101: Alex Morgan of Khosla Ventures
Gepubliceerd: 2-11-2023 -
All you need is d̶r̶u̶g̶s̶ energy: Motif Neurotech's Implants for Depression
Gepubliceerd: 20-10-2023
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
